-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

Benzinga·08/05/2026 20:27:49
语音播报
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $620 to $670.